Funding

This project was unfunded and workshops were conducted on personal time.

Conflicts of interest

Taichi Ochi, Macarius Donneyong, Enriqueta Vallejo-Yagüe, Arti V. Virkud and Juan M. Hincapie-Castillo have no conflicts of interest to declare. Harriet Dickinson is an employee and stockholder in Gilead Sciences Inc. Jan Feifel is an employee and stockholder of Merck KGaA. Katoo M. Muylle is an employee of AstraZeneca BeLux and her PhD research was supported by a grant from the Research Foundation Flanders (FWO) under grant number 1S39820N. Joseph Zabinski is an employee and stockholder of OM1. Victoria Y. Strauss is an employee of Boehringer Ingelheim Pharma GmBH & Co. KG. Philip Hunt was an employee and stockholder of AstraZeneca at the time of writing. Dana Y. Teltsch is an employee of Takeda, and owns stocks in Takeda and Aetion.

Ethics approval

Ethical approval was not required as this work does not contain any human subjects or patient-level data. Ethics approval was not sought for these workshops as no human data were involved.

Consent to participate

Consent to participate was also not required as no human subjects were involved.

Consent for publication

Consent for publication is not applicable as no patients were involved.

Availability of data and material (data transparency)

Data sharing is not applicable to this article as no datasets were analysed during the current study. No electronic supplementary material is provided.

Code availability

Code sharing is not applicable to this article as no code was generated during the current study. No electronic supplementary material is provided.

Authors’ contributions

HD conceived the idea for this manuscript and organised structured workshops. All authors decided on key themes and defined the scope of the manuscript, and HD, DT, JF, JZ, EVY, AV, KM, TO, MD, PH, VYS and JHC participated in workshops and subsequent offline discussions around key concepts. HD wrote the first draft from notes taken in the workshops. All authors reviewed the manuscript and approved the final version before submission.